Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Overview of recent developments in chronic lymphocytic leukemia.

Jain P, Rai KR.

South Asian J Cancer. 2012 Oct;1(2):84-9. doi: 10.4103/2278-330X.103721. Review.

2.

Prognostic factors and risk stratification in chronic lymphocytic leukemia.

Parikh SA, Shanafelt TD.

Semin Oncol. 2016 Apr;43(2):233-40. doi: 10.1053/j.seminoncol.2016.02.009. Epub 2016 Feb 8. Review.

PMID:
27040701
3.

Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.

Molica S, Giannarelli D, Levato L, Gentile M, Mirabelli R, Morabito F.

Clin Lymphoma Myeloma Leuk. 2015 Mar;15(3):e55-60. doi: 10.1016/j.clml.2014.09.003. Epub 2014 Sep 28.

PMID:
25445470
4.

The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.

Chen L, Li J, Zheng W, Zhang Y, Wu Y, Li L, Qian S, Xu W.

Leuk Lymphoma. 2007 Sep;48(9):1785-92.

PMID:
17786715
5.

Chronic lymphocytic leukemia (CLL)-Then and now.

Rai KR, Jain P.

Am J Hematol. 2016 Mar;91(3):330-40. doi: 10.1002/ajh.24282. Review.

6.

Signaling pathways activated by the B-cell receptor in chronic lymphocytic leukemia.

Scupoli MT, Pizzolo G.

Expert Rev Hematol. 2012 Jun;5(3):341-8. doi: 10.1586/ehm.12.21. Review.

PMID:
22780213
7.

IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.

Bulian P, Rossi D, Forconi F, Del Poeta G, Bertoni F, Zucca E, Montillo M, Pozzato G, D'Arena G, Efremov DG, Marasca R, Lauria F, Gaidano G, Gattei V, Laurenti L.

J Transl Med. 2012 Jan 30;10:18. doi: 10.1186/1479-5876-10-18.

8.

Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.

Morabito F, Mosca L, Cutrona G, Agnelli L, Tuana G, Ferracin M, Zagatti B, Lionetti M, Fabris S, Maura F, Matis S, Gentile M, Vigna E, Colombo M, Massucco C, Recchia AG, Bossio S, De Stefano L, Ilariucci F, Musolino C, Molica S, Di Raimondo F, Cortelezzi A, Tassone P, Negrini M, Monti S, Rossi D, Gaidano G, Ferrarini M, Neri A.

Clin Cancer Res. 2013 Nov 1;19(21):5890-900. doi: 10.1158/1078-0432.CCR-13-0622. Epub 2013 Sep 13.

9.

Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.

Karan-Djurasevic T, Palibrk V, Kostic T, Spasovski V, Nikcevic G, Srzentic S, Colovic M, Colovic N, Vidovic A, Antic D, Mihaljevic B, Pavlovic S, Tosic N.

Clin Lymphoma Myeloma Leuk. 2012 Aug;12(4):252-60. doi: 10.1016/j.clml.2012.03.005. Epub 2012 May 4.

PMID:
22560084
10.

CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.

Buhl AM, Jurlander J, Geisler CH, Pedersen LB, Andersen MK, Josefsson P, Petersen JH, Leffers H.

Eur J Haematol. 2006 Jun;76(6):455-64. Epub 2006 Mar 9.

PMID:
16529606
11.

Pathology consultation on evaluating prognosis in incidental monoclonal lymphocytosis and chronic lymphocytic leukemia.

Siddon AJ, Rinder HM; Education Committee of the Academy of Clinical Laboratory Physicians and Scientists.

Am J Clin Pathol. 2013 Jun;139(6):708-12. doi: 10.1309/AJCPLIR4GZWX3XKA. Review. Erratum in: Am J Clin Pathol. 2013 Aug;140(2):280.

PMID:
23690112
12.

HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?

Erikci AA, Karagoz B, Ozyurt M, Ozturk A, Kilic S, Bilgi O.

Hematology. 2009 Apr;14(2):101-5. doi: 10.1179/102453309X385197.

PMID:
19298722
13.

Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.

Rodríguez-Vicente AE, Díaz MG, Hernández-Rivas JM.

Cancer Genet. 2013 Mar;206(3):49-62. doi: 10.1016/j.cancergen.2013.01.003. Epub 2013 Mar 24. Review.

PMID:
23531595
14.

Chronic lymphocytic leukaemia: an immunobiology approach.

Kostareli E, Smilevska T, Stamatopoulos K, Kouvatsi A, Anagnostopoulos A.

Srp Arh Celok Lek. 2008 May-Jun;136(5-6):319-23. Review.

15.

Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment.

Morabito F, Cutrona G, Mosca L, D'Anca M, Matis S, Gentile M, Vigna E, Colombo M, Recchia AG, Bossio S, De Stefano L, Maura F, Manzoni M, Ilariucci F, Consoli U, Vincelli I, Musolino C, Cortelezzi A, Molica S, Ferrarini M, Neri A.

Leuk Res. 2015 Aug;39(8):840-5. doi: 10.1016/j.leukres.2015.05.005. Epub 2015 May 19.

PMID:
26038121
16.

FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.

Li FJ, Ding S, Pan J, Shakhmatov MA, Kashentseva E, Wu J, Li Y, Soong SJ, Chiorazzi N, Davis RS.

Blood. 2008 Jul 1;112(1):179-87. doi: 10.1182/blood-2008-01-131359. Epub 2008 Feb 26.

17.

Biological prognostic markers in chronic lymphocytic leukemia.

Vroblová V, Smolej L, Vrbacký F, Jankovicová K, Hrudková M, Malý J, Krejsek J.

Acta Medica (Hradec Kralove). 2009;52(1):3-8. Review.

18.

The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.

Hassab AH, Elbordiny MM, Elghandour AH, Sorour AF, Swelem RS.

Egypt J Immunol. 2011;18(2):77-93.

PMID:
23082473
19.

High expression of lymphocyte-activation gene 3 (LAG3) in chronic lymphocytic leukemia cells is associated with unmutated immunoglobulin variable heavy chain region (IGHV) gene and reduced treatment-free survival.

Kotaskova J, Tichy B, Trbusek M, Francova HS, Kabathova J, Malcikova J, Doubek M, Brychtova Y, Mayer J, Pospisilova S.

J Mol Diagn. 2010 May;12(3):328-34. doi: 10.2353/jmoldx.2010.090100. Epub 2010 Mar 12.

20.

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marcé S, López-Guillermo A, Campo E, Montserrat E.

N Engl J Med. 2003 May 1;348(18):1764-75.

Supplemental Content

Support Center